Levine Leichtman Capital Partners’ Investment in Prime Global Medical Communications

Levine Leichtman Capital Partners' Investment in Prime Global Medical Communications

Goodwin Procter LLP advised Levine Leichtman Capital Partners on the deal.

Levine Leichtman Capital Partners announced its investment in Prime Global Medical Communications Ltd. in partnership with its founder and management team.

Levine Leichtman Capital Partners is a middle-market private equity firm with a 37-year track record of investing across various targeted sectors, including franchising, professional services, education, and engineered products.

Prime Global is a global medical communications and market access group that provides the world’s leading biotech, pharmaceutical and healthcare businesses with full-service professional communications.

Prime Global will be the fifth investment by the new European fund, Levine Leichtman Capital Partners Europe II, SCSp.

The Goodwin team was led by Richard Lever (Picture) and consisted of Charles Elsom, Gartan Tracey, Stanislav Shishkin, and Jake Simons (Corporate), Simon Fulbrook, Richard Hughes, Nadim Islam, and Ayanda Kweyama (Finance), Robert Young and Matthew Birchall (Tax), and Ai Tajima (Litigation).

Involved fees earner: Matthew Birchall – Goodwin Procter; Charles Elsom – Goodwin Procter; Simon Fulbrook – Goodwin Procter; Richard Hughes – Goodwin Procter; Nadim Islam – Goodwin Procter; Richard Lever – Goodwin Procter; Stanislav Shishkin – Goodwin Procter; Ai Tajima – Goodwin Procter; Gartan Tracey – Goodwin Procter; Robert Young – Goodwin Procter;

Law Firms: Goodwin Procter;

Clients: Levine Leichtman Capital Partners;

Federica Tiefenthaler

Author: Federica Tiefenthaler